Kanagawa-ken, Japan

Takako Iwasaki


Average Co-Inventor Count = 12.6

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takako Iwasaki: Innovator in Pharmaceutical Compounds

Introduction

Takako Iwasaki is a prominent inventor based in Kanagawa-ken, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of tricyclic benzazepine compounds. With a total of 3 patents to her name, her work has had a notable impact on medicinal chemistry.

Latest Patents

Iwasaki's latest patents include innovative compounds that serve as intermediates for pharmacologically active tricyclic benzazepine and benzothiazepine derivatives. These patents detail compounds of formulae (II), (III), (IV), and (V), or salts thereof, which are crucial for the synthesis of these derivatives. The compounds feature various substituents, including hydrogen, alkyl, phenylalkyl, and protective groups of a triazole ring, showcasing her expertise in complex chemical structures.

Career Highlights

Throughout her career, Takako Iwasaki has worked with notable companies such as Meiji Seika Kabushiki Kaisha and Meiji Seika Kaisha, Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Iwasaki has collaborated with esteemed colleagues, including Yasuo Ohtsuka and Takashi Shishikura. These partnerships have fostered a collaborative environment that has led to innovative advancements in her field.

Conclusion

Takako Iwasaki's contributions to pharmaceutical innovations through her patents and collaborations highlight her as a key figure in the industry. Her work continues to influence the development of new medicinal compounds, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…